Yeshiva University: Experimental Drug May Prevent Chemotherapy Drug From Damaging the Heart
March 04, 2020
March 04, 2020
BRONX, New York, March 4 [TNSmedicalresearch] -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
The commonly used chemotherapy drug doxorubicin can damage heart muscle, in some cases leading to severe or lethal heart failure. A new study led by Albert Einstein College of Medicine researchers and involving zebrafish and mice suggests that the experimental drug BAI1 can prevent doxorubicin from damaging the heart without lessening its anti- . . .
The commonly used chemotherapy drug doxorubicin can damage heart muscle, in some cases leading to severe or lethal heart failure. A new study led by Albert Einstein College of Medicine researchers and involving zebrafish and mice suggests that the experimental drug BAI1 can prevent doxorubicin from damaging the heart without lessening its anti- . . .